Search research articles
Contact Us
Filters
Showing results (61-70 of 274) with videos related to
Page
of 28
Sort By:
Drugs
|
September 25, 2025
JAK Inhibitors for the Treatment of Vitiligo: Current Evidence and Emerging Therapeutic Potential
César Ferreira, Brett King, Tiago Torres
European Journal of Dermatology : EJD
|
November 25, 2020
Safety of secukinumab in psoriasis patients with latent tuberculosis infection
Álvaro Machado, Miguel Abreu, Tiago Torres
European Journal of Dermatology : EJD
|
July 26, 2021
A case of psoriasis and systemic lupus erythematous successfully treated with ustekinumab
Miguel Nogueira, Manuela Selores, Tiago Torres
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
June 8, 2019
Bimekizumab: The First Dual Inhibitor of Interleukin (IL)-17A and IL-17F for the Treatment of Psoriatic Disease and Ankylosing Spondylitis
Joel Reis, Ron Vender, Tiago Torres
The Journal of International Medical Research
|
March 12, 2024
Risankizumab, a therapeutic alternative for psoriasis in people living with HIV
Tomás Estevinho, Egídio Freitas, Tiago Torres
Australian Family Physician
|
May 12, 2016
Development of erythematous scaly lesions in a cervical surgical scar
Carla Ferreira da Silva, Tiago Torres
Drugs in Context
|
June 2, 2020
Psoriasis, biologic therapy, and the pandemic of the 21st century
Miguel Nogueira, Ron Vender, Tiago Torres
European Journal of Dermatology : EJD
|
November 7, 2013
Sacroiliitis in a psoriasis patient after switching from etanercept to ustekinumab
Susana Vilaça, Tiago Torres, Manuela Selores
Drugs
|
February 6, 2020
JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors
Miguel Nogueira, Luis Puig, Tiago Torres
Drugs
|
May 21, 2022
New Topical Therapies in Development for Atopic Dermatitis
Egídio Freitas, Melinda Gooderham, Tiago Torres
Page
of 28
Search research articles
Search
Showing results (61-70 of 274) with videos related to
Sort By:
Page
of 28
Drugs
|
September 25, 2025
JAK Inhibitors for the Treatment of Vitiligo: Current Evidence and Emerging Therapeutic Potential
César Ferreira, Brett King, Tiago Torres
European Journal of Dermatology : EJD
|
November 25, 2020
Safety of secukinumab in psoriasis patients with latent tuberculosis infection
Álvaro Machado, Miguel Abreu, Tiago Torres
European Journal of Dermatology : EJD
|
July 26, 2021
A case of psoriasis and systemic lupus erythematous successfully treated with ustekinumab
Miguel Nogueira, Manuela Selores, Tiago Torres
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
June 8, 2019
Bimekizumab: The First Dual Inhibitor of Interleukin (IL)-17A and IL-17F for the Treatment of Psoriatic Disease and Ankylosing Spondylitis
Joel Reis, Ron Vender, Tiago Torres
The Journal of International Medical Research
|
March 12, 2024
Risankizumab, a therapeutic alternative for psoriasis in people living with HIV
Tomás Estevinho, Egídio Freitas, Tiago Torres
Australian Family Physician
|
May 12, 2016
Development of erythematous scaly lesions in a cervical surgical scar
Carla Ferreira da Silva, Tiago Torres
Drugs in Context
|
June 2, 2020
Psoriasis, biologic therapy, and the pandemic of the 21st century
Miguel Nogueira, Ron Vender, Tiago Torres
European Journal of Dermatology : EJD
|
November 7, 2013
Sacroiliitis in a psoriasis patient after switching from etanercept to ustekinumab
Susana Vilaça, Tiago Torres, Manuela Selores
Drugs
|
February 6, 2020
JAK Inhibitors for Treatment of Psoriasis: Focus on Selective TYK2 Inhibitors
Miguel Nogueira, Luis Puig, Tiago Torres
Drugs
|
May 21, 2022
New Topical Therapies in Development for Atopic Dermatitis
Egídio Freitas, Melinda Gooderham, Tiago Torres
Page
of 28